Search clinical trials for: BLI-489

Total 2625 results

The University of Texas Health Science Center,...

Completed

Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention

Increase HPV Vaccination Uptake | Delay Sexual Debut

United States
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Personalized Feedback Programs for College Students

Alcohol Use, Unspecified

United States
National University Hospital, Singapore
National University, Singapore; Agency for Science, Technology and Research

Completed

Assistive Soft Robotic Glove Intervention Using Brain-Computer Interface for Elderly Stroke Patients

Stroke

Singapore
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

A Trial of E-cigarettes in Current Cigarette Smokers

Smoking | Nicotine Dependence | Nicotine Dependence, Other Tobacco Product

United States
Central Hospital, Nancy, France

Completed

Qualitative Assessment of the Brief Contact Intervention "Stay in Contact" in Suicide Prevention (EVAREST2)

Suicide and Self-harm

France
Yale University

Completed

Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

Breast Cancer | Early Stage Estrogen Receptor (ER) Positive Breast Cancer

United States
Betta Pharmaceuticals Co., Ltd.

Suspended

Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy

Non-small Cell Lung Cancer

China
Celgene

Active, not recruiting

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission (QUAZAR AML-001)

Leukemia, Myeloid, Acute

United States, Australia, Brazil, Canada, Czechia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Spain, United Kingdom, Belgium, Taiwan, Austria, Ireland, Israel, Lithuania, Poland, Turkey
Amgen

Completed

Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal Cancer
Ataturk University

Recruiting

The Effect of Combined Spinal Epidural Anaesthesia on QTc Interval Undergoing Cesarean Section

Analgesia

Turkey
Ankara University

Enrolling by invitation

The Effect of Different Simulation Methods Used in Adult Basic Life Support Training

First Aid

Turkey
Boehringer Ingelheim

Terminated

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

Head and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung

Netherlands
University of Birmingham

Active, not recruiting

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT (AMADEUS)

Acute Myeloid Leukemia | Myelodysplasia

United Kingdom
Bayer

Completed

Efficacy and Tolerability of Angeliq in Thai Women

Postmenopause
Boehringer Ingelheim

Completed

BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis

Pulmonary Disease, Chronic Obstructive

Germany
Boehringer Ingelheim

Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Small Cell Lung Carcinoma | Neuroendocrine Neoplasms

United States, Belgium, Spain, Korea, Republic of, United Kingdom, Germany, Japan, China, Taiwan, France, Portugal, Bulgaria
University of British Columbia

Not yet recruiting

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease (ProD)

Depression | Parkinson Disease
Hoffmann-La Roche

Terminated

A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma

Multiple Myeloma

Austria
Boehringer Ingelheim

Completed

Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809

Healthy

Germany
University of New Mexico

Completed

The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 Diabetics

Insulin Resistance | Type 2 Diabetes

United States
Abramson Cancer Center at Penn Medicine
ImaginAb, Inc.

Enrolling by invitation

Zr89 + PET Companion Trial

Melanoma (Skin)

United States
Universidad Autonoma de Nuevo Leon

Completed

Comparison of Early Versus Very Early Postnatal Discharge on Hospital Readmissions in Newborns

Hospital Readmission | Newborn Morbidity | Newborn | Newborn Complication
Temple University
Medical University of South Carolina; National Institute of Neurological Disorders... and other collaborators

Completed

Study of Procoagulation Markers in Stroke Patients (I-SPOT)

Hyperglycemia | Stroke | Procoagulation Markers

United States
Boehringer Ingelheim

Completed

This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer

Neoplasms

Korea, Republic of, Taiwan, Japan
Boehringer Ingelheim

Withdrawn

A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2

COVID-19
Boehringer Ingelheim

Recruiting

A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body

Healthy

Germany
Bergen University College
University of Bergen; Duke University; Haukeland University Hospital; University... and other collaborators

Active, not recruiting

Assessment and Treatment of Patients With Long-term Dizziness in Primary Care (LODIP)

Vertigo | Dizziness | Vestibular Neuritis

Norway
Boehringer Ingelheim

Recruiting

A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

Patients With Small Cell Lung Carcinoma and Other Neoplasms

United States, Spain, Germany, Japan
Boehringer Ingelheim

Withdrawn

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone

Asthma
Alaxia SAS

Terminated

Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients

Bronchiectasis | Cystic Fibrosis

France
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI); National Center for Advancing...

Terminated

Water and Sudafed in Autonomic Failure

Multiple System Atrophy | Shy-Drager Syndrome

United States
Botanix Pharmaceuticals

Completed

A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis

Hyperhidrosis

United States
ROGER S KERESZTES MD

Terminated

Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy

Carcinoma, Non-Small-Cell Lung

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D) (C2H-D)

Stress, Psychological | Mood

United States
Bahceci Health Group
Uskudar University

Unknown

Women's Quality of Life, Sexual Life and Psychological State in Patients Undergoing Embryo Transfers

Depression | Quality of Life | Anxiety State | Infertility, Female | Sexual Function and Fertility Disorders

Turkey
Betta Pharmaceuticals Co., Ltd.

Unknown

Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease

NSCLC

China
Roswell Park Cancer Institute

Withdrawn

Icotinib Hydrochloride in Treating Patients With Advanced Cancers

Unspecified Adult Solid Tumor, Protocol Specific
Maastricht Radiation Oncology
Amsterdam UMC, location VUmc

Completed

Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients (Cetuximab Zr89)

Stage IV Cancer

Netherlands
Boehringer Ingelheim

Completed

A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body

Healthy

Belgium
University of North Carolina, Chapel Hill
Massachusetts General Hospital; National Institute of Diabetes and Digestive... and other collaborators

Recruiting

Food as Medicine for HIV and Diabetes (FAME-H)

HIV Infections | Diabetes Mellitus, Type 2 | PreDiabetes

United States
Blueprint Medicines Corporation

Completed

(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

Gastrointestinal Stromal Tumors (GIST) | Other Relapsed or Refractory Solid Tumors

United States, United Kingdom, France, Korea, Republic of, Belgium, Germany, Italy, Netherlands, Poland, Spain
University Hospital, Montpellier
European Commission

Completed

Medical Device for Drug Allergy Diagnosis (COBIOPHAD)

Drug Hypersensitivity

France
Blueprint Medicines Corporation

Approved for marketing

Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC

Non-Small Cell Lung Cancer | Medullary Thyroid Cancer
HonorHealth Research Institute
Neolight

Completed

Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns

Neonatal Hyperbilirubinemia | Jaundice, Neonatal | Neonatal Disorder

United States
UNC Lineberger Comprehensive Cancer Center
GlaxoSmithKline

Withdrawn

Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas

Lymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, B-Cell, Marginal Zone | Lymphoma, Low-Grade | Lymphoma, Intermediate-Grade
DUSA Pharmaceuticals, Inc.

Completed

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Actinic Keratosis

United States
National Institute of Neurological Disorders and...

Recruiting

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

Multiple Sclerosis | Progressive Multifocal Leukoencephalopathy

United States
National Cancer Center, China

Not yet recruiting

A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations (EGFR)

NSCLC
Blue Lake Biotechnology Inc.

Recruiting

A Study of BLB-201 RSV Vaccine in Infants and Children

Respiratory Syncytial Virus Infections

United States
Celgene

Completed

Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada

Search clinical trials for: BLI-489

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations